Brian Cogley
Fortune : 476 100 $ au 30/06/2026
Fortune : 476 100 $ au 30/06/2026
Brian Cogley is currently Chief Financial Officer & Director at NOK Therapeutics, Inc. since 2024, Chief Financial Officer at Coeptis Therapeutics, Inc. since 2023, and Chief Financial Officer at Z Squared, Inc. starting in 2026.
Former roles include Senior Manager-Accounting Advisory at Cfgi LLC, Vice President-Finance & Accounting at NexTier Bank, NA from 2017 to 2022, and Chief Financial Officer at Coeptis Therapeutics Holdings, Inc. Education includes undergraduate and MBA degrees from Duquesne University of The Holy Spirit.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,09 % | 27/04/2026 | 45 000 ( 0,09 % ) | 476 100 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NAERODYNAMICS INC | Directeur Financier/CFO | 17/05/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
NexTier Bank, NA
NexTier Bank, NA Major BanksFinance Provides national banking solutions | Directeur Financier/CFO | 01/02/2022 |
| COEPTIS THERAPEUTICS | Directeur Financier/CFO | - |
Cfgi LLC /Privategroup/
Cfgi LLC /Privategroup/ Financial ConglomeratesFinance Acts as a private group led by CVC Advisors (US) Inc and management and existing investor of CFGI LLC | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies novel therapy products for cancer patients | Health Technology |
Duquesne University of The Holy Spirit
Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NexTier Bank, NA
NexTier Bank, NA Major BanksFinance Provides national banking solutions | Finance |
Cfgi LLC /Privategroup/
Cfgi LLC /Privategroup/ Financial ConglomeratesFinance Acts as a private group led by CVC Advisors (US) Inc and management and existing investor of CFGI LLC | Finance |
Coeptis Therapeutics Holdings, Inc.
Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national